INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (6)
2022
-
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Cancer Cell, Vol. 40, Núm. 11, pp. 1358-1373.e8
2021
2016
2015
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171
2009
-
The research mission in myeloma
Leukemia